Compare Cytokinetics Inc (CYTK) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs SMX Security Matters plc — how do they compare? Cytokinetics Inc trades at $76.52 (market cap $10.63B), while SMX Security Matters plc trades at $16.4 (market cap $17.04M). The key difference: Cytokinetics Inc is far larger — about 623.8× SMX Security Matters plc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| CYTK | SMX | |
|---|---|---|
Market Cap | $10.63B | $17.04M |
Sector | Technology | Technology |
52-Week High | $87.26 | $103.71K |
52-Week Low | $34.31 | $12.87 |
Enterprise Value | $10.74B | -$14.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $77.07, down 0.54% on the day, with a bearish technical signal from moving averages. The company reported a Q2 2026 loss of $1.50 per share, beating estimates, but revenue of $68 million in 2026 reflects a net loss margin of -1,321.12%. Recent UK approval for MYQORZO and positive NICE guidance provide commercial momentum, yet high SG&A costs and negative cash flow from operations highlight ongoing financial strain.
The outlook hinges on MYQORZO's commercial execution and label expansion, with a consensus price target of $111.14 implying 44% upside. Risks include sustained cash burn, competitive pressure, and reliance on aficamten's clinical success. Analyst sentiment is overwhelmingly bullish, but profitability remains distant.
SMX trades at $15.77, down 0.19% with a bearish technical signal from moving averages. The company reported significant losses with -$169.18M net income for 2025 and negative ROE of -819.22%, though recent news highlights balance sheet strengthening and commercialization progress in recycled plastics traceability. Cash flow remains dependent on financing activities.
Outlook remains challenged by persistent losses and negative profitability metrics, offset by positioning in the growing recycled plastics verification market. Key risks include execution on commercialization and cash burn. Institutional sentiment appears mixed amid fundamental weakness but potential regulatory tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
